Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Balance at Oct. 31, 2021 $ 34,767 $ 301 $ 239,927 $ (204,790) $ 35,438 $ (671)
Balance, shares at Oct. 31, 2021   30,050,894        
Stock option compensation to employees and directors 4,928 4,928 4,928
Common stock issued upon exercise of stock options and warrants 830 $ 6 824 830
Common stock issued upon exercise of stock options and warrants, shares   577,473        
Common stock issued to consultants 72 72 72
Common stock issued to consultants, shares   22,662        
Net loss (10,242) (10,119) (10,119) (123)
Balance at Jul. 31, 2022 30,907 $ 307 246,303 (214,909) 31,701 (794)
Balance, shares at Jul. 31, 2022   30,653,418        
Stock options and warrants issued to consultants 546 546 546
Common stock issued pursuant to employee stock purchase plan 6 6 6
Common stock issued pursuant to employee stock purchase plan, shares   2,389        
Balance at Apr. 30, 2022 31,406 $ 302 244,032 (212,163) 32,171 (765)
Balance, shares at Apr. 30, 2022   30,154,708        
Stock option compensation to employees and directors 1,329 1,329 1,329
Stock options issued to consultants 109 109 109
Common stock issued upon exercise of stock options and warrants 830 $ 5 825 830
Common stock issued upon exercise of stock options and warrants, shares   496,048        
Common stock issued to consultants 8 8 8
Common stock issued to consultants, shares   2,662        
Net loss (2,775) (2,746) (2,746) (29)
Balance at Jul. 31, 2022 30,907 $ 307 246,303 (214,909) 31,701 (794)
Balance, shares at Jul. 31, 2022   30,653,418        
Balance at Oct. 31, 2022 28,200 $ 309 247,123 (218,385) 29,047 (847)
Balance, shares at Oct. 31, 2022   30,913,902        
Stock option compensation to employees and directors 3,265 3,265 3,265
Common stock issued upon exercise of stock options and warrants 81 $ 1 80 81
Common stock issued upon exercise of stock options and warrants, shares   84,411        
Common stock issued to consultants 67 67 67
Common stock issued to consultants, shares   17,554        
Net loss (7,209) (7,121) (7,121) (88)
Balance at Jul. 31, 2023 24,585 $ 310 250,716 (225,506) 25,520 (935)
Balance, shares at Jul. 31, 2023   31,017,770        
Stock options and warrants issued to consultants 175 175 175
Common stock issued pursuant to employee stock purchase plan 6 6 6
Common stock issued pursuant to employee stock purchase plan, shares   1,903        
Balance at Apr. 30, 2023 25,913 $ 310 249,496 (222,995) 26,811 (898)
Balance, shares at Apr. 30, 2023   30,958,665        
Stock option compensation to employees and directors 1,153 1,153 1,153
Stock options issued to consultants 47 47 47
Common stock issued upon exercise of stock options and warrants 3 3 3
Common stock issued upon exercise of stock options and warrants, shares   55,029        
Common stock issued to consultants 17 17 17
Common stock issued to consultants, shares   4,076        
Net loss (2,548) (2,511) (2,511) (37)
Balance at Jul. 31, 2023 $ 24,585 $ 310 $ 250,716 $ (225,506) $ 25,520 $ (935)
Balance, shares at Jul. 31, 2023   31,017,770